ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

FillPoint Health Forms Collaborative Partnership with Noble, an Aptar Pharma Company, to Enhance Patient Experience and Drive Treatment Adherence

FillPoint Health, a Lyceum Health company and URAC/ACHC-accredited specialty pharmacy and MSO, announced today a strategic partnership with Noble, an Aptar Pharma company and global leader in drug delivery training and onboarding solutions. This collaboration aims to enhance the patient experience through provider engagement and pharmaceutical partnerships, ensuring proper device use, improved adherence, and better clinical outcomes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106648637/en/

Under this partnership, FillPoint Health and Noble will jointly develop and implement education and support programs that integrate Noble’s industry-leading training devices, patient onboarding tools, and education platforms into FillPoint’s provider-driven specialty pharmacy model. The collaboration will focus on bridging the gap between pharmaceutical manufacturers, healthcare providers, and patients, creating a consistent, high-touch experience from prescription to administration.

“Our partnership with Noble represents a critical step in advancing how specialty therapies are delivered and supported at the point of care,” said Michael Baldzicki, Chief Revenue Officer of FillPoint Health. “By combining Noble’s proven patient training expertise with FillPoint’s provider-centric pharmacy model, we can help patients start therapy with confidence, use their medications correctly, and stay adherent over time—ultimately improving outcomes and satisfaction.”

The collaboration aligns with FillPoint Health’s broader mission of empowering providers and patients through technology, education, and integrated care models. As part of Lyceum Health’s network, FillPoint Health partners with pharmaceutical manufacturers and specialty providers to deliver fair market value (FMV)-based services, risk-of-loss pharmacy models, and real-world data insights that enhance access, quality, and efficiency in specialty care.

“We’re excited to partner with FillPoint Health to further our shared vision of improving patient engagement and outcomes,” said Craig Baker, President, Noble – Aptar Pharma. “Together, we will leverage our complementary strengths to ensure patients are fully supported in their treatment journey, from training to adherence.”

The partnership will initially focus on key therapeutic areas—including cardiology, dermatology, neurology, and rare diseases—with plans to expand into additional specialty categories and manufacturer collaborations throughout 2026.

About FillPoint Health, A Lyceum Health Company

FillPoint Health is a URAC- and ACHC-accredited specialty pharmacy and MSO focused on enhancing specialty patient care through integrated provider, payer, and pharmaceutical partnerships. FillPoint operates as part of Lyceum Health, a group of companies that includes RxNexus, a digital patient-access platform, and NewPoint-Rx, a physician-dispense division enabling compliant, FMV-based, in-office dispensing. For more info, please visit fillpointhealth.com and lyceumhealth.com.

About Noble, An Aptar Pharma Company

Noble is an Aptar Pharma company and part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Noble is a global leader in the development of patient-centric onboarding and drug delivery training solutions designed to improve the patient experience and drive adherence. Noble partners with pharmaceutical and biotechnology companies worldwide to create innovative, user-friendly training and support programs that empower patients to start and stay on therapy. For more information, please visit gonoble.com and www.aptar.com.

“By combining Noble’s proven patient training expertise with FillPoint’s provider-centric pharmacy model, we can help patients start therapy with confidence, use their medications correctly, and stay adherent over time—ultimately improving outcomes."

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.